RNA Research Solutions
-
K1047 HyperScribe™ T7 High Yield RNA Synthesis KitSummary: For high-efficiency in vitro transcription -
R1005 Firefly Luciferase mRNA (ARCA, 5mCTP, ψUTP)Summary: Better performance of firefly luciferase mRNA modified by ARCA, 5mCTP and ΨUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control. -
B8596 ALC-0159Summary: ALC-0159 is a lipid excipient. ALC-0159-containing formulation have been used to develop lipid nanoparticles (LNPs) for the delivery of mRNA-based vaccines. -
R1027 EZ Cap™ OVA mRNASummary: Ovalbumin mRNA with Cap 1 structure, providing higher transcription efficiency -
R1030 EZ Cap™ Cre mRNA (m1Ψ)1 CitationSummary: Cre mRNA with Cap 1 structure, modified by m1Ψ, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation -
K1812 RNA Clean BeadsSummary: RNA Purification Magnetic Beads, the perfect alternative to Agencourt RNACLEAN XP. -
R1057 EZ Cap™ Human IL-12 mRNA (m1Ψ，HA tag)Summary: Human IL-12 mRNA with Cap 1 structure and HA tag sequence., modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1115 EZ Cap™ Mito-EGFP Probe mRNA (m1Ψ)Summary: Mitochondria (Mito) probes mRNA with EGFP, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
K1046 RNase Inhibitor, Murine26 CitationSummary: Murine RNase Inhibitor -
B8595 ALC-0315Summary: ALC-0315 is an ionizable amino lipid that can be combined with other lipids to form lipid nanoparticles (LNP). LNP containing ALC-0315 can be utilized for the delivery of mRNA vaccines.